[go: up one dir, main page]

EP3347458A4 - Cochon multi-transgénique pour xénogreffe - Google Patents

Cochon multi-transgénique pour xénogreffe Download PDF

Info

Publication number
EP3347458A4
EP3347458A4 EP16845199.5A EP16845199A EP3347458A4 EP 3347458 A4 EP3347458 A4 EP 3347458A4 EP 16845199 A EP16845199 A EP 16845199A EP 3347458 A4 EP3347458 A4 EP 3347458A4
Authority
EP
European Patent Office
Prior art keywords
xenograffe
transgenic pig
transgenic
pig
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16845199.5A
Other languages
German (de)
English (en)
Other versions
EP3347458A1 (fr
Inventor
David L. Ayares
Carol Phelps
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revivicor Inc
Original Assignee
Revivicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Revivicor Inc filed Critical Revivicor Inc
Publication of EP3347458A1 publication Critical patent/EP3347458A1/fr
Publication of EP3347458A4 publication Critical patent/EP3347458A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8778—Swine embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A01K2217/206—Animal model comprising tissue-specific expression system, e.g. tissue specific expression of transgene, of Cre recombinase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A01K2267/025—Animal producing cells or organs for transplantation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
EP16845199.5A 2015-09-09 2016-09-09 Cochon multi-transgénique pour xénogreffe Pending EP3347458A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562216225P 2015-09-09 2015-09-09
US201562256068P 2015-11-16 2015-11-16
PCT/US2016/051126 WO2017044864A1 (fr) 2015-09-09 2016-09-09 Cochon multi-transgénique pour xénogreffe

Publications (2)

Publication Number Publication Date
EP3347458A1 EP3347458A1 (fr) 2018-07-18
EP3347458A4 true EP3347458A4 (fr) 2019-08-07

Family

ID=58240236

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16845199.5A Pending EP3347458A4 (fr) 2015-09-09 2016-09-09 Cochon multi-transgénique pour xénogreffe

Country Status (8)

Country Link
US (1) US20180249688A1 (fr)
EP (1) EP3347458A4 (fr)
JP (4) JP7050665B2 (fr)
KR (2) KR20250161669A (fr)
CN (2) CN108473963A (fr)
AU (3) AU2016319131B2 (fr)
CA (1) CA2998187A1 (fr)
WO (1) WO2017044864A1 (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
CN105939767B (zh) 2014-01-08 2018-04-06 弗洛设计声能学公司 具有双声电泳腔的声电泳装置
WO2016126831A1 (fr) 2015-02-03 2016-08-11 Mayo Foundation For Medical Education And Research Méthodes et matériels d'évaluation et de traitement de l'arthrite
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
AU2016261600B2 (en) 2015-05-08 2021-09-23 President And Fellows Of Harvard College Universal donor stem cells and related methods
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
WO2018041118A1 (fr) 2016-08-31 2018-03-08 Beijing Biocytogen Co., Ltd Animal non humain génétiquement modifié avec pd-l1 humain ou chimérique
EP3519570B1 (fr) * 2016-09-29 2022-06-08 F. Hoffmann-La Roche AG Procédé d'analyse et d'optimisation de modules d'édition génique et approches de délivrance
KR102746223B1 (ko) 2017-04-20 2024-12-27 이제네시스, 인크. 유전자 변형 동물의 생성 방법
KR102363891B1 (ko) * 2017-04-28 2022-02-17 서울대학교산학협력단 ＨＯ-1 유전자 및 ＴＮＦＲ1-Ｆｃ 유전자를 동시에 발현하며 GGTA1 유전자 및 CMAH 유전자가 넉아웃된 형질전환 돼지 및 이의 용도
KR101945877B1 (ko) * 2017-06-08 2019-02-12 대한민국 인간 mcp 및 인간 tbm 발현용 유전자 구조체 및 이를 포함하는 벡터
CN108103098B (zh) 2017-12-14 2020-07-28 华南理工大学 一种化合物皮肤致敏体外评估细胞模型及其构建方法
EP3725092A4 (fr) 2017-12-14 2021-09-22 FloDesign Sonics, Inc. Circuit d'excitation et circuit de commande de transducteur acoustique
AU2019246406B2 (en) * 2018-03-29 2025-01-23 Bruno Reichart Compositions for prolonging the survival after orthopic and heteropic xenogeneic heart, kidney, lung or liver transplantations
CN109045357B (zh) * 2018-06-11 2019-09-13 武汉奥翔生物科技有限公司 种源皮肤及其制备方法
KR102103103B1 (ko) 2018-08-16 2020-04-21 (주)라트바이오 인위적 뉴클레아제를 생산하는 형질전환 동물 및 형질전환 배아
EP3847267A1 (fr) * 2018-09-08 2021-07-14 Blueallele, LLC Procédés et compositions pour modifier le gène du facteur de von willebrand
WO2020072982A1 (fr) 2018-10-05 2020-04-09 Xenotherapeutics, Inc. Produits et procédés de xénotransplantation
US10883084B2 (en) 2018-10-05 2021-01-05 Xenotherapeutics, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
WO2020077144A1 (fr) * 2018-10-10 2020-04-16 Revivicor, Inc. Compositions et méthodes de prévention des allergies
US11679179B2 (en) * 2018-11-09 2023-06-20 Universite Paris Descartes Detection of bioprosthetic valve degeneration
WO2020127332A1 (fr) * 2018-12-17 2020-06-25 Consejo Superior De Investigaciones Científicas (Csic) Procédé d'introduction d'informations génétiques dans une cellule par un système d'intégration spécifique de site
EP3945799A1 (fr) * 2019-03-25 2022-02-09 Xenotherapeutics, Inc. Cellules, tissus et organes personnalisés pour une transplantation à partir d'un donneur (non humain) humanisé, sur mesure, conçu sans pathogène, et procédés et produits associés
WO2021072778A1 (fr) * 2019-10-18 2021-04-22 Egenesis, Inc. Cellules, tissus, organes et/ou animaux ayant un ou plusieurs gènes modifiés pour une survie et/ou une tolérance à une xénogreffe améliorée
WO2021072777A1 (fr) * 2019-10-18 2021-04-22 Egenesis, Inc. Cellules, tissus, organes et/ou animaux ayant un ou plusieurs gènes modifiés pour une survie et/ou une tolérance à une xénogreffe améliorée
KR20220033468A (ko) * 2019-05-16 2022-03-16 이제네시스, 인크. 강화된 이종이식편 생존 및/또는 내성을 위한 하나 이상의 변형된 유전자를 갖는 세포, 조직, 장기 및/또는 동물
CN110373391A (zh) * 2019-06-10 2019-10-25 云南农业大学 一种适合心脏异种移植供体猪的构建方法
CN110373392A (zh) * 2019-06-10 2019-10-25 云南农业大学 一种适合肾脏异种移植供体猪的构建方法
CN110373389A (zh) * 2019-06-10 2019-10-25 云南农业大学 一种适合胰岛细胞及皮肤等组织异种移植供体猪的构建方法
CA3143597A1 (fr) * 2019-06-17 2020-12-24 Mayo Foundation For Medical Education And Research Preparations de prevotella et traitement de la bronchopneumopathie chronique obstructive (bpco) et d'autres affections pulmonaires
CN110305872A (zh) * 2019-07-17 2019-10-08 中国农业科学院北京畜牧兽医研究所 小型猪2型糖尿病模型的构建方法及应用
KR102176161B1 (ko) * 2019-07-23 2020-11-09 주식회사 옵티팜 돼지 내인성 레트로바이러스 Envlope C 음성, GGTA1, CMAH, iGb3s, β4GalNT2 유전자가 넉아웃되고, 인간 CD46 및 TBM 유전자를 발현하는 이종장기이식을 위한 형질전환 복제돼지 및 이의 제조방법
CN111296364B (zh) * 2019-10-27 2022-06-24 上海莱士血液制品股份有限公司 一种基因改造的小鼠动物模型基因改造方法及其应用
DK3811777T3 (da) 2019-10-27 2024-09-02 Shanghai Raas Blood Products Co Ltd Genetisk modificerede ikke-humane dyr humaniseret til protein c
CN112741046A (zh) * 2019-10-31 2021-05-04 成都中医药大学附属医院 一种copd合并气管支气管软化症模型的构建方法
US20220409669A1 (en) * 2019-12-02 2022-12-29 The General Hospital Corporation Nerve Xenografts and Related Methods
IL294519A (en) * 2020-01-07 2022-09-01 Hangzhou Qihan Biotechnology Co Ltd Methods and compositions for production of xenogeneic islet cells and treatment of insulin-resistant or -deficient conditions with the same
CN113368306A (zh) * 2020-03-23 2021-09-10 成都中科奥格生物科技有限公司 低免疫原性生物材料及其制备方法和用途
CN113429475A (zh) * 2020-03-23 2021-09-24 成都中科奥格生物科技有限公司 一种胶原材料及其制备方法和用途
CN111778251A (zh) * 2020-07-14 2020-10-16 金佩奇生物科技(南京)有限公司 敲除猪异种抗原的基因的gRNA及其应用
CN111955422A (zh) * 2020-08-21 2020-11-20 五邑大学 一种可用于异种器官移植的供体猪的构建方法
EP4244352A4 (fr) * 2020-11-13 2024-10-16 Egenesis, Inc. Cellules, tissus, organes et animaux ayant un ou plusieurs gènes modifiés pour une survie et une tolérance de xénogreffe améliorées
US20220211018A1 (en) * 2020-11-20 2022-07-07 Revivicor, Inc. Multi-transgenic pigs with growth hormone receptor knockout for xenotransplantation
CN115232813B (zh) * 2021-07-15 2025-11-11 南京启真基因工程有限公司 用于构建vWF基因突变的血管性血友病模型猪核移植供体细胞的基因编辑系统及其应用
KR102641015B1 (ko) * 2021-08-04 2024-02-27 대한민국 항염증 및 면역 억제 유전자 발현을 위한 구조체가 도입된 gtko/cmahko 세포주와 이의 용도
US20230255185A1 (en) * 2021-09-20 2023-08-17 Revivicor, Inc. Multitransgenic pigs comprising ten genetic modifications for xenotransplantation
KR102738812B1 (ko) * 2021-12-16 2024-12-09 주식회사 옵티팜 돼지 GGTA1, CMAH, β4GalNT2 및 CD40 유전자가 결손된 이종장기이식을 위한 형질전환 복제돼지 및 이의 제조방법
GB202218755D0 (en) * 2022-12-13 2023-01-25 Replay Holdings Llc Compositions and methods for non-immunogenicity
WO2024245959A1 (fr) * 2023-05-26 2024-12-05 Eckhard Wolf Cellule porcine génétiquement modifiée, porc génétiquement modifié et leurs procédés de production
CN117099743B (zh) * 2023-07-11 2025-12-05 吉林大学 一种snx6基因不表达的异种移植供体及制备方法
KR102722231B1 (ko) * 2023-12-15 2024-10-28 주식회사 옵티팜 돼지 GGTA1, CMAH, iGb3s, β4GalNT2 유전자가 결손되고 인간 CD59 유전자가 넉인된 이종수혈 및 이종장기이식을 위한 형질전환 복제돼지 및 이의 제조방법
WO2025235683A1 (fr) 2024-05-07 2025-11-13 Eledon Pharmaceuticals, Inc. Procédés et compositions pour la prévention du rejet de greffe

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012112586A1 (fr) * 2011-02-14 2012-08-23 Revivicor, Inc. Cochons génétiquement modifiés destinés à la xénotransplantation de xénogreffes vascularisées et de dérivés de celles-ci
WO2014066505A1 (fr) * 2012-10-24 2014-05-01 Indiana University Research & Technology Corporation Cochons, organes et tissus à double inactivation (gt/cmah-ko)
WO2016065046A1 (fr) * 2014-10-22 2016-04-28 Indiana University Research & Technology Corporation Porcs triples transgéniques appropriés pour la xénogreffe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518482B2 (en) * 1994-09-13 2003-02-11 American National Red Cross Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor
WO2009069986A2 (fr) * 2007-11-30 2009-06-04 Korea Research Institute Of Bioscience And Biotechnology Lignée cellulaire génétiquement modifiée pour produire des porcs miniatures clonés pour une xénotransplantation et son procédé de préparation
AU2010282239A1 (en) * 2009-08-14 2012-03-08 Revivicor, Inc. Multi-transgenic pigs for diabetes treatment
WO2013188358A1 (fr) * 2012-06-12 2013-12-19 The General Hospital Corporation Porc transgénique miniature pour un ou plusieurs facteurs de coagulation
US20130347134A1 (en) * 2012-06-21 2013-12-26 Thomas Diacovo Transgenic von willebrand factor animals and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012112586A1 (fr) * 2011-02-14 2012-08-23 Revivicor, Inc. Cochons génétiquement modifiés destinés à la xénotransplantation de xénogreffes vascularisées et de dérivés de celles-ci
WO2014066505A1 (fr) * 2012-10-24 2014-05-01 Indiana University Research & Technology Corporation Cochons, organes et tissus à double inactivation (gt/cmah-ko)
WO2016065046A1 (fr) * 2014-10-22 2016-04-28 Indiana University Research & Technology Corporation Porcs triples transgéniques appropriés pour la xénogreffe

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
2009 Joint Meeting of the International Pancreas and Islet Transplant Association (IPITA) and the International Xenotransplantation Association (IXA): Friday, October 16, 2009: IXA Parallel Session 7: Genetic Engineering of the Donor Species. *
AYARES, DAVID ET AL.: "Genetic engineering of source pigs for xenotransplantation: Progress and prospects", XENOTRANSPLANTATION , SEPTEMBER-OCTOBER 2013, vol. 20, no. 5, 408, 20 September 2013 (2013-09-20), pages 361, XP002790002, ISSN: 0908-665X *
DAVID KC COOPER ET AL: "Recent advances in understanding xenotransplantation: implications for the clinic", EXPERT REVIEW OF CLINICAL IMMUNOLOGY, vol. 11, no. 12, 1 September 2015 (2015-09-01), GB, pages 1379 - 1390, XP055572199, ISSN: 1744-666X, DOI: 10.1586/1744666X.2015.1083861 *
DONALD G. HARRIS ET AL: "Meta-analysis of the independent and cumulative effects of multiple genetic modifications on pig lung xenograft performance during ex vivo perfusion with human blood", XENOTRANSPLANTATION, vol. 22, no. 2, 2 December 2014 (2014-12-02), US, pages 102 - 111, XP055572928, ISSN: 0908-665X, DOI: 10.1111/xen.12149 *
HAYATO IWASE ET AL: "Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts", XENOTRANSPLANTATION, vol. 24, no. 2, 17 March 2017 (2017-03-17), US, pages e12293, XP055571105, ISSN: 0908-665X, DOI: 10.1111/xen.12293 *
HAYATO IWASE ET AL: "Pig kidney graft survival in a baboon for 136 days: longest life-supporting organ graft survival to date", XENOTRANSPLANTATION, vol. 22, no. 4, 29 June 2015 (2015-06-29), US, pages 302 - 309, XP055571529, ISSN: 0908-665X, DOI: 10.1111/xen.12174 *
HILTON GOCK,MARK NOTTLE, ANDREW M.LEW, ANTHONY J.F.D'APICE, PETER COWAN: "Genetic modification of pigs for solid organ xenotransplantation", TRANSPLANTATION REVIEWS, vol. 25, no. 1, 1 January 2011 (2011-01-01), pages 9 - 20, XP002790003 *
IXA 2013 - Joint Congress of IXA and Organ Transplantation in ABO-incompatible and Hyperimmunized Recipients 2013: Early Morning Workshop 3: Strategies for Overcoming Xenograft Loss. https://onlinelibrary.wiley.com/doi/epdf/10.1111/xen.12060_22 *
KONRAD FISCHER ET AL: "Multi-transgenic pigs for xenotransplantation", XENOTRANSPLANTATION, vol. 20, 1 January 2013 (2013-01-01), pages 39 - 64, XP055449880, DOI: 10.1111/xen.12014 *
NELLA FISICARO ET AL: "Versatile co-expression of graft-protective proteins using 2A-linked cassettes : Transgene co-expression using 2A", XENOTRANSPLANTATION, vol. 18, no. 2, 1 March 2011 (2011-03-01), US, pages 121 - 130, XP055572913, ISSN: 0908-665X, DOI: 10.1111/j.1399-3089.2011.00631.x *
SALVARIS, EVELYN ET AL.: "IXA-O-7.1: Multi-gene Constructs to Accelerate the Generation of Multi-transgenic GalT knockout pigs", XENOTRANSPLANTATION. SEPTEMBER 2009, vol. 16, no. 5, September 2009 (2009-09-01), pages 373, XP002790004 *
See also references of WO2017044864A1 *
TANG HAI ET AL: "One-step generation of knockout pigs by zygote injection of CRISPR/Cas system", CELL RESEARCH - XIBAO YANJIU, vol. 24, no. 3, 31 January 2014 (2014-01-31), GB, CN, pages 372 - 375, XP055227259, ISSN: 1001-0602, DOI: 10.1038/cr.2014.11 *
WEI DENG ET AL: "Use of the 2A Peptide for Generation of Multi-Transgenic Pigs through a Single Round of Nuclear Transfer", PLOS ONE, vol. 6, no. 5, 13 May 2011 (2011-05-13), pages e19986, XP055570804, DOI: 10.1371/journal.pone.0019986 *
XIAOPING LI ET AL: "Rosa26-targeted swine models for stable gene over-expression and Cre-mediated lineage tracing", CELL RESEARCH, vol. 24, no. 4, 7 February 2014 (2014-02-07), Singapore, pages 501 - 504, XP055390685, ISSN: 1001-0602, DOI: 10.1038/cr.2014.15 *

Also Published As

Publication number Publication date
KR20250161669A (ko) 2025-11-17
JP2023119041A (ja) 2023-08-25
US20180249688A1 (en) 2018-09-06
AU2022268274B2 (en) 2025-08-21
CA2998187A1 (fr) 2017-03-16
EP3347458A1 (fr) 2018-07-18
JP2021101741A (ja) 2021-07-15
JP2018526015A (ja) 2018-09-13
WO2017044864A1 (fr) 2017-03-16
AU2016319131B2 (en) 2022-10-13
NZ740687A (en) 2025-06-27
AU2016319131A1 (en) 2018-03-29
JP7050665B2 (ja) 2022-04-08
CN115380872A (zh) 2022-11-25
AU2025208575A1 (en) 2025-08-14
AU2022268274A1 (en) 2022-12-15
KR20180056419A (ko) 2018-05-28
CN108473963A (zh) 2018-08-31
KR102883068B1 (ko) 2025-11-06
JP2025092572A (ja) 2025-06-19

Similar Documents

Publication Publication Date Title
EP3347458A4 (fr) Cochon multi-transgénique pour xénogreffe
EP3541932A4 (fr) Inhibiteurs de crispr-cas9
EP3393410A4 (fr) Insert personnalisable pour stomie
EP3344319A4 (fr) Connecteurs pour conduits
LT3303334T (lt) Tirozinkinazės inhibitoriai
EP3313828A4 (fr) Inhibiteurs de métallo-bêta-lactamases
CU20160125A7 (es) Inhibidores de diacilglicerol aciltransferasa 2
BR112017000042A2 (pt) inibidores de desmetilase-1 lisina-específica
LT3386954T (lt) Dimeriniai kontrastiniai agentai
EP3630078A4 (fr) Agents pour chimio-embolisation
FR3036518B1 (fr) Inversion pour contrainte tectonique
DK3186242T3 (da) Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere
MA50533A (fr) Imipridones pour gliomes
MA43367A (fr) Inhibiteurs de métallo-bêta-lactamases
EP3519028A4 (fr) Étrier pour harnais
EP3398042A4 (fr) Suppression d'arrière-plan
EP4067461C0 (fr) Procédé de réduction du point d'écoulement à efficacité élevée
EP3325857A4 (fr) Segment racleur
EP3378585A4 (fr) Composition pour liaison
FR3017684B1 (fr) Profile pour joint
EP3405864A4 (fr) Mystification cpuid pour rétrocompatibilité
EP3525786A4 (fr) Inhibiteurs de kdm5
FR3029931B1 (fr) Flanc pour pneumatique
FR3029930B1 (fr) Flanc pour pneumatique
EP3426309A4 (fr) Radioligands pour la myéline

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180409

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: AYARES, DAVID, L.

Inventor name: PHELPS, CAROL

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A01N 1/02 20060101ALI20190325BHEP

Ipc: C12N 15/90 20060101ALI20190325BHEP

Ipc: A01K 67/027 20060101AFI20190325BHEP

Ipc: C12N 5/16 20060101ALI20190325BHEP

Ipc: C12N 15/867 20060101ALI20190325BHEP

Ipc: C12N 5/10 20060101ALI20190325BHEP

Ipc: C12N 15/877 20100101ALI20190325BHEP

Ipc: C12N 15/85 20060101ALI20190325BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20190705

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/877 20100101ALI20190701BHEP

Ipc: A01N 1/02 20060101ALI20190701BHEP

Ipc: C12N 15/867 20060101ALI20190701BHEP

Ipc: C12N 5/10 20060101ALI20190701BHEP

Ipc: A01K 67/027 20060101AFI20190701BHEP

Ipc: C12N 15/85 20060101ALI20190701BHEP

Ipc: C12N 15/90 20060101ALI20190701BHEP

Ipc: C12N 5/16 20060101ALI20190701BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210507